STAT’s most memorable photos of 2019 – STAT
Our contributing photographers have covered stories about love and devastating loss and told patient stories about their fight for treatments.
Our contributing photographers have covered stories about love and devastating loss and told patient stories about their fight for treatments.
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird flu passed the virus on…
A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients are being steered…
Is Sam Altman right in suggesting an AI will replace the PI in cancer research? It comes down to the nature of creative thinking, says…
After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.
We generally don’t think of rare-disease advocacy as funny. But Sammy Basso, who died at 28, will be remembered for his ability to find laughter…
The CEO of the American Heart Association urges Congress to prevent deaths from cardiac arrest by passing the HEARTS Act.
Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup led by an executive…
Since late 2023, Kaiser has been giving some of its Parkinson’s patients an Apple Watch app called StrivePD, developed by Rune Labs.
Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But